Drug: ABREVA Injury: Application site swelling Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126103181 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160801 | US |
126341081 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 16.00 YR | F | 0 | 20160809 | US |
126733481 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160822 | US |
127366322 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 0.00 | 0 | 20160919 | US | |
127709331 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 0.00 | 0 | 20160922 | US | |
127801081 | ABREVA | Application site swelling | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160926 | US |
Total Records: 6 Number of Pages: 1